Attendere, elaborazione in corso…

Logo PROGETTO UE METROMRT

METROMRT

Metrology for molecular radioteraphy

Informazioni Generali

Coordinatore:
NPL NATIONAL PHYSICAL LABORATORY (Regno Unito)
Responsabile:
D'ARIENZO MARCO - FSN-INMRI (CASACCIA)
Ruolo ENEA:
PARTNER

Programmi Europei

Programma:
Other programmes -> EMRP (2007-2013) (N/A - Non applicabile)

Descrizione e Attività

Descrizione Generale

Scientific Objectives
• To develop the TDCR Cerenkov technique for primary standard activity measurements of highactivity high-energy beta-emitters (such as 32P, 89Sr, 90Y); the objective is to obtain on the one hand, a primary activity standard for 90Y microspheres based on the TDCR Cerenkov technique, on the other hand, a reliable standard transfer protocol to end-users for 90Y microspheres
• To improve the accuracy of the knowledge of the shape of beta spectra required for activity measurements using the TDCR Cerenkov technique as well as for absorbed dose measurements
• To investigate methods for validation and calibration of quantitative radionuclide imaging with the aim of developing/identifying suitable phantoms for use for dosimetry audits and traceable calibration transfer
To investigate the performance of a range of image reconstruction and correction algorithms
employed for quantitative imaging, using measurements and Monte Carlo simulation, in order to provide objective evidence for preferred methods
• To develop advice and guidelines for standard procedures for quantitative activity measurements and verification/calibration using SPECT-CT and PET-CT
• To investigate possible methodologies for the direct measurement of absorbed energy in a range of suitable media and geometries, from a selected number of radionuclides, for the purposes of achieving measurement traceability to a primary standard of absorbed dose and for validating the dose calculation methods used in patient dosimetry
• To analyse and model the dosimetry chain in order to estimate the uncertainty component in each link, and to assess the implications for the health and medical research communities of reducing these uncertainties.

Attività svolta da ENEA

L'ENEA coordina il WP3 (sviluppo di uno standard primario per la misura della dose assorbita nei trattamenti di radioterapia molecolare necessario alla validazione delle tecniche di valutazione della dose impiegata clinicamente). Partecipa inoltre a tutti gli altri WPs.

Dati Finanziari (in euro)

Costo Eleggibile

Progetto:
2.575.362,00
ENEA:
432.724,00

Contributo

Progetto:
1.140.885,00
ENEA:
191.697,00

Durata del Progetto

Anno di stipula e Durata:
2012 - 36 mesi
Periodo:
01-06-2012 -> 31-05-2015

Partner (13)

Ruolo Nome Nazione
CEA - COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES Francia
PTB PHYSIKALISCH TECHNISCHE BUNDESANSTALT Germania
AUSL LATINA Italia
IFO ISTITUTI FISIOTERAPICI OSPEDALIERI Italia
ISS - ISTITUTO SUPERIORE DI SANITA Italia
VSL B.V. DUTCH METROLOGY INSTITUTE Paesi Bassi
ICR ROYAL CANCER HOSPITAL Regno Unito
THE CHRISTIE NHS FOUNDATION TRUST Regno Unito
UNIV. COLLEGE LONDON Regno Unito
VELINDRE NATIONAL HEALTH SERVICE TRUST Regno Unito
UNIV. LUND Svezia
COORD NPL NATIONAL PHYSICAL LABORATORY Regno Unito
PARTNER ENEA Italia

Keyword CORDIS (5)

Keyword Argomento
Medical Research Biological Sciences
MEDICINE, HEALTH Biological Sciences
Applied Metrology Measurements and Standards
INNOVATION, TECHNOLOGY TRANSFER RTD Horizontal Topics
SCIENTIFIC RESEARCH RTD Horizontal Topics

Altre Keyword (1)

Keyword
Cancer therapy